RAP 0.00% 20.5¢ resapp health limited

Cap Raising - Q4 FY21, page-6

  1. 381 Posts.
    lightbulb Created with Sketch. 727
    For what it may or may not be worth to each individual the following is the answer given in the January conference call as to the need for a cap raise -

    “So right now, we have a lot of flexibility with that balance sheet. I mean, we have $4.2 million in the bank. We're expecting a relatively large R&D tax incentive rebate within the next month or so. We've just received some funding from EMDG, the Export Market Development Grants.

    So we have a lot of flexibility with the cash that we've got in the bank.

    Obviously, at a point in time, depending on what our revenue cash flow forecast looks like, funding may need to come from potential partners or maybe needed to come from shareholders. We're not sure at this stage.

    But at this point in time, we have a number of quarters up our sleeves to make a significant difference in the commercialisation and hopefully make a significant difference in the revenue line as well.”

    poorinvestor
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.